ANATOMIC STAGE IB BREAST CANCER AJCC V8
Clinical trials for ANATOMIC STAGE IB BREAST CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new ANATOMIC STAGE IB BREAST CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for ANATOMIC STAGE IB BREAST CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising combo for Hard-to-Treat breast cancer hits roadblock
Disease control TerminatedThis study tested a combination of two drugs (nab-paclitaxel and alpelisib) given before surgery to people with a specific type of triple-negative breast cancer that didn't respond to standard chemotherapy. The goal was to see if the combo could shrink or eliminate tumors. Only 6…
Matched conditions: ANATOMIC STAGE IB BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 06:16 UTC
-
Phone support aims to ease daily life for young black breast cancer survivors
Symptom relief TerminatedThis study tested a program called Y-AMBIENT, designed to improve quality of life for young African American women (ages 18-44) with stage I-III breast cancer who were undergoing chemotherapy or radiation. The program involved phone sessions, videos, and written materials over fo…
Matched conditions: ANATOMIC STAGE IB BREAST CANCER AJCC V8
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated May 26, 2026 06:20 UTC
-
Can a gut pill stop chemo stomach woes? trial tests rifaximin for breast cancer patients
Symptom relief TerminatedThis study tested the antibiotic rifaximin in 20 people with early-stage HER2-positive breast cancer who had stomach problems from pertuzumab-based chemotherapy. The goal was to see if rifaximin could reduce side effects like diarrhea and belly pain, helping patients stay on thei…
Matched conditions: ANATOMIC STAGE IB BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 18, 2026 12:07 UTC